Multiple Sclerosis [MS] vs SmartMS BI

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Sclerosis @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Sclerosis @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated multiple sclerosis content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients

SmartMS BI presents statistical data, generated by SmartMS (System for Monitoring, aid, registration and treatment of Multiple Sclerosis). Presented data contains information, based on Electronical Health Records (EHRs)of Bulgarian patients with MS. SmartMS EHRs have two main sources of information – health care specialists (HCPs) and patients. Advanced networking model and role based access gives patients and HCPs the best of EHRs, while keeping their data save and accessible. SmartMS BI covers MS patients, who are being treated with disease modifying drugs (DMDs) and contains information, which could be valuable for pharma companies, clinical research organizations (CROs), distributers, public funds, etc.